(Q44595455)

4 December 2017

0 references

Statins and cancer: a case of meta-uncertainty (English)

1 reference

4 December 2017

E Guallar

1

1 reference

4 December 2017

S N Goodman

series ordinal

2

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

American Journal of Medicine

4 December 2017

published in

1 reference

4 December 2017

volume

110

1 reference

4 December 2017

issue

9

1 reference

4 December 2017

page(s)

738-740

1 reference

Current perspectives on statins

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900758-6

Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900758-6

Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900758-6

Risk factor modification: rationale for management of dyslipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900758-6

Carcinogenicity of lipid-lowering drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900758-6

Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900758-6

Are there potential non-lipid-lowering uses of statins?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900758-6

Do statins cause cancer? A meta-analysis of large randomized clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900758-6

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900758-6

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900758-6

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900758-6

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900758-6

Systematic Reviews in Health Care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900758-6

Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900758-6

3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer: a nested case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900758-6

Probability at the bedside: the knowing of chances or the chances of knowing?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900758-6

10.1016/S0002-9343(01)00758-6

7 January 2021

Identifiers

DOI

1 reference

4 December 2017

1 reference